Cargando…
HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling
The prevalence of pretreatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) is >10% in many low-income countries. As a consequence, several sub-Saharan African countries have implemented, or are considering the introduction of, non-NNRTI-based first-line antiretroviral t...
Autores principales: | de Waal, Reneé, Lessells, Richard, Hauser, Anthony, Kouyos, Roger, Davies, Mary-Ann, Egger, Matthias, Wandeler, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248850/ https://www.ncbi.nlm.nih.gov/pubmed/30515315 |
Ejemplares similares
-
Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa
por: Hauser, Anthony, et al.
Publicado: (2019) -
Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study
por: Hauser, Anthony, et al.
Publicado: (2020) -
Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub‐Saharan Africa: Systematic review and meta‐analysis
por: Surial, Bernard, et al.
Publicado: (2020) -
Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa
por: Coffie, Patrick A., et al.
Publicado: (2017) -
A New Generation of Physicians in Sub-Saharan Africa?
: Comment on "Non-physician Clinicians in Sub-Saharan Africa and the Evolving Role of Physicians"
por: Dussault, Gilles, et al.
Publicado: (2016)